34577551|t|Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues.
34577551|a|Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment. Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in lymphomas treatment. In Vorinostat, we replaced the hydrophobic phenyl group with various tricyclic 'caps' possessing a central, eight-membered, heterocyclic ring, and investigated the HDAC activity and cytotoxic effect on the cancer and normal cell lines. We found that 3 out of the 19 compounds, based on dibenzo[b,f]azocin-6(5H)-one, 11,12-dihydrodibenzo[b,f]azocin-6(5H)-one, and benzo[b]naphtho[2,3-f][1,5]diazocine-6,14(5H,13H)-dione scaffolds, showed better HDACs inhibition than the referenced Vorinostat. In leukemic cell line MV4-11 and in the lymphoma cell line Daudi, three compounds showed lower IC50 values than Vorinostat. These compounds had higher activity and selectivity against MV4-11 and Daudi cell lines than reference Vorinostat. We also observed a strong correlation between HDACs inhibition and the cytotoxic effect. Cell lines derived from solid tumours: A549 (lung carcinoma) and MCF-7 (breast adenocarcinoma) as well as reference BALB/3T3 (normal murine fibroblasts) were less susceptible to compounds tested. Developed derivatives show improved properties than Vorinostat, thus they could be considered as possible agents for leukemia and lymphoma treatment.
34577551	9	13	HDAC	Gene	9734
34577551	35	44	Cytotoxic	Disease	MESH:D064420
34577551	83	106	Leukemias and Lymphomas	Disease	MESH:D007938
34577551	127	137	Vorinostat	Chemical	MESH:D000077337
34577551	170	174	HDAC	Gene	9734
34577551	220	226	cancer	Disease	MESH:D009369
34577551	286	296	Vorinostat	Chemical	MESH:D000077337
34577551	301	305	HDAC	Gene	9734
34577551	324	333	lymphomas	Disease	MESH:D008223
34577551	348	358	Vorinostat	Chemical	MESH:D000077337
34577551	509	513	HDAC	Gene	9734
34577551	527	536	cytotoxic	Disease	MESH:D064420
34577551	551	557	cancer	Disease	MESH:D009369
34577551	631	659	dibenzo[b,f]azocin-6(5H)-one	Chemical	-
34577551	661	702	11,12-dihydrodibenzo[b,f]azocin-6(5H)-one	Chemical	-
34577551	708	763	benzo[b]naphtho[2,3-f][1,5]diazocine-6,14(5H,13H)-dione	Chemical	-
34577551	826	836	Vorinostat	Chemical	MESH:D000077337
34577551	841	849	leukemic	Disease	MESH:D007938
34577551	860	866	MV4-11	CellLine	CVCL:0064
34577551	878	886	lymphoma	Disease	MESH:D008223
34577551	897	902	Daudi	CellLine	CVCL:0008
34577551	950	960	Vorinostat	Chemical	MESH:D000077337
34577551	1022	1028	MV4-11	CellLine	CVCL:0064
34577551	1033	1038	Daudi	CellLine	CVCL:0008
34577551	1065	1075	Vorinostat	Chemical	MESH:D000077337
34577551	1148	1157	cytotoxic	Disease	MESH:D064420
34577551	1190	1203	solid tumours	Disease	MESH:D009369
34577551	1205	1209	A549	CellLine	CVCL:0023
34577551	1211	1225	lung carcinoma	Disease	MESH:D008175
34577551	1231	1236	MCF-7	CellLine	CVCL:0031
34577551	1238	1259	breast adenocarcinoma	Disease	MESH:D001943
34577551	1282	1290	BALB/3T3	CellLine	CVCL:0184
34577551	1299	1317	murine fibroblasts	CellLine	CVCL:0594
34577551	1414	1424	Vorinostat	Chemical	MESH:D000077337
34577551	1479	1487	leukemia	Disease	MESH:D007938
34577551	1492	1500	lymphoma	Disease	MESH:D008223
34577551	Negative_Correlation	MESH:D000077337	MESH:D008223
34577551	Positive_Correlation	MESH:D000077337	MESH:D064420
34577551	Negative_Correlation	MESH:D000077337	9734
34577551	Negative_Correlation	MESH:D000077337	MESH:D007938

